 Amphetamine-Related Disorders
"Amphetamine-Related Disorders" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Disorders related or resulting from use of amphetamines.
| Descriptor ID |
D019969
|
| MeSH Number(s) |
C25.225 F03.900.225
|
| Concept/Terms |
Amphetamine-Related Disorders- Amphetamine-Related Disorders
- Amphetamine Related Disorders
- Disorder, Amphetamine-Related
- Disorders, Amphetamine-Related
Amphetamine Addiction- Amphetamine Addiction
- Addiction, Amphetamine
- Amphetamine Dependence
- Dependence, Amphetamine
|
Below are MeSH descriptors whose meaning is more general than "Amphetamine-Related Disorders".
Below are MeSH descriptors whose meaning is more specific than "Amphetamine-Related Disorders".
This graph shows the total number of publications written about "Amphetamine-Related Disorders" by people in UAMS Profiles by year, and whether "Amphetamine-Related Disorders" was a major or minor topic of these publications.
To see the data from this visualization as text, click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2024 | 1 | 0 | 1 | | 2021 | 1 | 0 | 1 | | 2020 | 1 | 0 | 1 | | 2019 | 1 | 0 | 1 | | 2018 | 3 | 0 | 3 | | 2017 | 1 | 0 | 1 | | 2015 | 0 | 2 | 2 | | 2014 | 1 | 2 | 3 | | 2013 | 2 | 0 | 2 | | 2012 | 2 | 0 | 2 | | 2011 | 1 | 1 | 2 | | 2010 | 4 | 1 | 5 | | 2009 | 2 | 0 | 2 | | 2007 | 3 | 1 | 4 | | 2006 | 2 | 0 | 2 | | 2005 | 0 | 1 | 1 |
To return to the timeline, click here.
Below are the most recent publications written about "Amphetamine-Related Disorders" by people in Profiles over the past ten years.
-
Pro G, Hayes C, Mancino M. Worsening trends in the frequency of methamphetamine and other stimulant use between treatment admission and discharge. Drug Alcohol Depend. 2024 Sep 01; 262:111403.
-
Thompson RG, Oliveto A, Thostenson JD, Wilson MP, McGaugh J, Mancino MJ. Utility of a controlled amphetamine withdrawal paradigm among adults who use methamphetamine: A pilot clinical trial. J Psychopharmacol. 2021 11; 35(11):1420-1430.
-
Hay CE, Ewing LE, Hambuchen MD, Zintner SM, Small JC, Bolden CT, Fantegrossi WE, Margaritis P, Owens SM, Peterson EC. The Development and Characterization of an scFv-Fc Fusion-Based Gene Therapy to Reduce the Psychostimulant Effects of Methamphetamine Abuse. J Pharmacol Exp Ther. 2020 07; 374(1):16-23.
-
Cucciare MA, Ounpraseuth ST, Curran GM, Booth BM. Predictors of mental health and substance use disorder treatment use over 3 years among rural adults using stimulants. Subst Abus. 2019; 40(3):363-370.
-
Hay CE, Gonzalez GA, Ewing LE, Reichard EE, Hambuchen MD, Nanaware-Kharade N, Alam S, Bolden CT, Owens SM, Margaritis P, Peterson EC. Development and testing of AAV-delivered single-chain variable fragments for the treatment of methamphetamine abuse. PLoS One. 2018; 13(6):e0200060.
-
Lee NR, Zheng G, Crooks PA, Bardo MT, Dwoskin LP. New Scaffold for Lead Compounds to Treat Methamphetamine Use Disorders. AAPS J. 2018 02 09; 20(2):29.
-
Kangiser MM, Dwoskin LP, Zheng G, Crooks PA, Stairs DJ. Varenicline and GZ-793A differentially decrease methamphetamine self-administration under a multiple schedule of reinforcement in rats. Behav Pharmacol. 2018 02; 29(1):87-97.
-
Cucciare MA, Han X, Timko C, Zaller N, Kennedy KM, Booth BM. Correlates of three-year outpatient medical care use among rural stimulant users. J Subst Abuse Treat. 2017 06; 77:6-12.
|
People  People who have written about this concept. _
Similar Concepts
People who have written about this concept.
_
Top Journals
Top journals in which articles about this concept have been published.
|